The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

August 17, 2024

Study Completion Date

August 15, 2025

Conditions
RemimazolamAnesthesia AwarenessSedative, Hypnotic, or Anxiolytic Withdrawal
Interventions
DRUG

Remimazolam besylate

Thirty patients underwent elective lower extremity surgery receive spinal anesthesia, and then remimazolam besylate was given intravenously with an induction dose of 3mg/min. When the MOAA/S (Modified Observer's Assessment of Alertness/Sedation) score was ≤1, remimazolam besylate was maintained at 1mg/min for 24min, and finally stopped. Wavelet index, MOAA/S score, blood pressure, heart rate, respiratory rate, and pulse oxygen saturation were continuously monitored during the period.

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER

NCT06427785 - The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate | Biotech Hunter | Biotech Hunter